tradingkey.logo
tradingkey.logo
Pesquisar

Evotec SE

EVO
Adicionar à lista de desejos
1.580USD
-0.080-4.82%
Fechamento 11-13 16:00(ET)
561.51MValor de mercado
PerdaP/L TTM

Sobre o Evotec SE Empresa

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Evotec SE Perfil

Código da empresaEVO
Nome da EmpresaEvotec SE
Data de listagemOct 11, 1999
CEOWojczewski (Christian)
Número de funcionários4827
Tipo de títulosDepository Receipt
Fim do ano fiscalOct 11
EndereçoEssener Bogen 7
CidadeHAMBURG
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísGermany
Código postal22419
Telefone4940560810
Sitehttps://www.evotec.com/
Código da empresaEVO
Data de listagemOct 11, 1999
CEOWojczewski (Christian)

Executivos da empresa Evotec SE

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Joanna Holbrook
Dr. Joanna Holbrook
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Dr. Wolfgang Hofmann
Dr. Wolfgang Hofmann
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Dr. Sarah Fakih
Dr. Sarah Fakih
Executive Vice President Head of Global Communications & Investor Relations
Executive Vice President Head of Global Communications & Investor Relations
--
--
Ms. Claire Hinshelwood
Ms. Claire Hinshelwood
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mr. Dieter Weinand
Mr. Dieter Weinand
Chairwoman of the Supervisory Board
Chairwoman of the Supervisory Board
--
--
Dr. Ashiq H. Khan
Dr. Ashiq H. Khan
Chief Commercial Officer, Member of the Management Board
Chief Commercial Officer, Member of the Management Board
--
--
Mr. Wesley Wheeler
Mr. Wesley Wheeler
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Joanna Holbrook
Dr. Joanna Holbrook
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Dr. Wolfgang Hofmann
Dr. Wolfgang Hofmann
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Dr. Sarah Fakih
Dr. Sarah Fakih
Executive Vice President Head of Global Communications & Investor Relations
Executive Vice President Head of Global Communications & Investor Relations
--
--
Ms. Claire Hinshelwood
Ms. Claire Hinshelwood
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mr. Dieter Weinand
Mr. Dieter Weinand
Chairwoman of the Supervisory Board
Chairwoman of the Supervisory Board
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Evotec SE?

Os cinco principais acionistas de Evotec SE são: Dr. Cord Dohrmann, Ph.D.

Quantas instituições possuem ações da Evotec SE (EVO)?

Em 2026Q1, 81 instituições possuíam ações da Evotec SE, com valor de mercado aproximado de 9.58M, representando 2.69% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -584606.00.
tradingkey.logo
Aviso de risco: Nosso site e aplicativo móvel fornecem apenas informações gerais sobre determinados produtos de investimento. A Finsights não oferece, e o fornecimento de tais informações não deve ser interpretado como se a Finsights estivesse oferecendo, aconselhamento financeiro ou recomendação para qualquer produto de investimento.
Os produtos de investimento estão sujeitos a riscos significativos, incluindo a possível perda do valor investido e podem não ser adequados para todos. O desempenho passado dos produtos de investimento não é indicativo de seu desempenho futuro.
A Finsights pode permitir que anunciantes ou afiliados realizem, ou forneçam anúncios em nosso site, ou aplicativo móvel, ou em qualquer parte deles e pode ser compensada por eles com base em sua interação com os anúncios.
 © Copyright: FINSIGHTS MEDIA PTE. LTD. Todos os direitos reservados.